Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination

Biochemistry and Cell Biology

Volumn 85, Issue 2, 2007, Pages 218-226

  Zheng, Yan ^a   Zhao, Wei Ming ^a   Wang, Hong ^a   Zhou, Ya Bin ^a   Luan, Yi ^a   Qi, Mei ^a   Cheng, Yi Zhe ^a   Tang, Wei ^a   Liu, Juan ^a   Yu, Han ^a   Yu, Xiu Ping ^a   Fan, Yi Jun ^b   Yang, Xi ^b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Chlamydia trachomatis; Codon; DNA immunization; MOMP; mRNA expression; Protein expression

Indexed keywords

CHLAMYDIA TRACHOMATIS; CODONS; DNA IMMUNIZATION; MRNA EXPRESSION; PROTEIN EXPRESSION;

ANTIBODIES; DNA SEQUENCES; GENES; IMMUNOLOGY; OPTIMIZATION; PATHOGENS; VACCINES;

BIOCHEMISTRY;

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; MAJOR OUTER MEMBRANE PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; BIOTYPE; CELL STIMULATION; CHLAMYDIA TRACHOMATIS; CODON USAGE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DNA SEQUENCE; DNA VECTOR; GENE SYNTHESIS; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN MODIFICATION; SPLEEN CELL; T LYMPHOCYTE; VACCINATION; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; BACTERIAL OUTER MEMBRANE PROTEINS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CODON; FEMALE; GENES, BACTERIAL; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; VACCINES, DNA;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; HOMO SAPIENS; MAMMALIA; MUS;

EID: 34249684877     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O06-211     Document Type: Conference Paper

References (42)

1. Andre, S., Seed, B., Eberle, J., Schraut, W., Bultmann, A., and Haas, J. 1998. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72: 1497-1503.
2. Baehr, W., Zhang, Y.X., Joseph, T., Su, H., Nano, F.E., Everett, K.D., and Caldwell, H.D. 1988. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc. Natl. Acad. Sci. U.S.A. 85: 4000-4004. doi:10.1073/pnas.85.11.4000.
3. Brunham, R.C., Zhang, D.J., Yang, X., and McClarty, G.M. 2000. The potential for vaccine development against chlamydial infection and disease. J. Infect. Dis. 181: Suppl. 3, S538-S543. doi:10.1086/315630.
4. Bulmer, M. 1987. Coevolution of codon usage and transfer RNA abundance. Nature (London), 325: 728-730. doi:10.1038/325728a0.
5. Cid-Arregui, A., Juarez, V., and zur Hausen, H. 2003. Synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J. Virol. 77: 4928-4937. doi:10.1128/JVI.77.8.4928-4937.2003.
6. Deml, L., Bojak, A., Steck, S., Graf, M., Wild, J., Schirmbeck, R., Wolf, H., and Wagner, R. 2001. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J. Virol. 75: 10991-11001. doi:10.1128/JVI.75.22.10991-11001.2001.
7. Disbrow, G.L., Sunitha, I., Baker, C.C., Hanover, J., and Schlegel, R. 2003. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology, 311: 105-114. doi:10.1016/S0042-6822(03)00129-6.
8. Duan, J., and Antezana, M.A. 2003. Mammalian mutation pressure, synonymous codon choice, and mRNA degradation. J. Mol. Evol. 57: 694-701. doi:10.1007/s00239-003-2519-1.
9. Grantham, R., Gautier, C., and Gouy, M. 1980. Codon frequencies in 119 individual genes confirm consistent choices of degenerate bases according to genome type. Nucleic Acids Res. 8: 1893-1912.
10. Haas, J., Park, E.C., and Seed, B. 1996. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6: 315-324. doi:10.1016/S0960-9822(02)00482-7.
11. Koide, Y., Nagata, T., Uchijima, M., Yoshida, A., and Aoshi, T. 1999. DNA vaccines for infections with intracellular bacteria. Nippon Saikingaku Zasshi, 54: 773-793.
12. Konu, O., and Li, M.D. 2002. Correlations between mRNA expression levels and GC contents of coding and untranslated regions of genes in rodents. J. Mol. Evol. 54: 35-41. doi:10.1007/s00239-001-0015-Z.
13. Kudla, G., Lipinski, L., Caffin, F., Helwak, A., and Zylicz, M. 2006. High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol. 4: e180. doi:10.1371/journal.pbio.0040180.
14. Kurts, C. 2000. Cross-presentation: inducing CD8 T cell immunity and tolerance. J. Mol. Med. 78: 326-332. doi:10.1007/ s001090000108.
15. Leder, C., Kleinschmidt, J.A., Wiethe, C., and Müller, M. 2001. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J. Virol. 75: 9201-9209. doi:10.1128/JVI.75.19.9201-9209.2001.
16. Martin, C.E., and Scheinbach, S. 1989. Expression of proteins encoded by foreign genes in Saccharomyces cerevisiae. Biotechnol. Adv. 7: 155-185. doi:10.1016/0734-9750(89)90357-1.
17. McNulty, D.E., Claffee, B.A., Huddleston, M.J., Porter, M.L., Cavnar, K.M., and Kane, J.F. 2003. Mistranslational errors associated with the rare arginine codon CGG in Escherichia coli. Protein Expr. Purif. 27: 365-374.
18. Morrison, R.P., and Caldwell, H.D. 2002. Immunity to murine chlamydial genital infection. Infect. Immun. 70: 2741-2751. doi:10.1128/IAI.70.6. 2741-2751.2002.
19. Nagata, T., Uchijima, M., Yoshida, A., Kawashima, M., and Koide, Y. 1999. Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem. Biophys. Res. Commun. 261: 445-451. doi:10.1006/bbrc.1999.1050.
20. Nguyen, K.L., Ilano, M., Akari, H., Miyagi, E., Poeschla, E.M., Strebel, K., and Bour, S. 2004. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology, 319: 163-175. doi:10.1016/j.virol.2003.11.021.
21. Nusbaum, M.R., Wallace, R.R., Slatt, L.M., and Kondrad, E.C. 2004. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus. J. Am. Osteopath. Assoc. 104: 527-535.
22. Pal, S., Luke, C.J., Barbour, A.G., Peterson, E.M., and de la Maza, L.M. 2003. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge. Vaccine, 21: 1455-1465. doi:10.1016/S0264-410X(02)00680-1.
23. Penttila, T., Vuola, J.M., Puurula, V., Anttila, M., Sarvas, M., Rautonen, N., Makela, P.H., and Puolakkainen, M. 2000. Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2). Vaccine, 19: 1256-1265. doi:10.1016/S0264-410X(00)00237-1.
24. Rice, P., Longden, I., and Bleasby, A. 2000. EMBOSS:the European molecular biology open software suite. Trends Genet. 16: 276-277. doi:10.1016/S0168-9525(00)02024-2.
25. Semon, M., Mouchiroud, D., and Duret, L. 2005. Relationship between gene expression and GC-content in mammals: Statistical significance and biological relevance. Hum. Mol. Genet. 14: 421-427.
26. Sharp, P.M., and Matassi, G. 1994. Codon usage and genome evolution. Curr. Opin. Genet. Dev. 4: 851-860. doi:10.1016/0959-437X(94)90070-1.
27. Sharp, P.M., Averof, M., Lloyd, A.T., Matassi, G., and Peden, J.F. 1995. DNA sequence evolution: the sounds of silence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 349: 241-247.
28. Silins, I., Ryd, W., Strand, A., Wadell, G., Tornberg, S., Hansson, B.G., et al. 2005. Chlamydia trachomatis infection and persistence of human papillomavirus. Int. J. Cancer, 116: 110-115. doi:10.1002/ijc.20970.
29. Stamm, W.E. 1999. Chlamydia trachomatis infections: progress and problems. J. Infect. Dis. 179: Suppl. 2, S380-S383.
30. Steinberg, T., Ohlschlager, P., Sehr, P., Osen, W., and Gissmann, L. 2005. Modification of HPV 16 E7 genes: correlation between the level of protein expression and CTL response after immunization of C57BL/6 mice. Vaccine, 23: 1149-1157. doi:10.1016/j.vaccine.2004.08.027.
31. Stratford, R., Douce, G., Zhang-Barber, L., Fairweather, N., Eskola, J., and Dougan, G. 2000. Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine, 19: 810-815. doi:10.1016/S0264-410X(00) 00246-2.
32. Sueoka, N., and Kawanishi, Y. 2000. DNA G+C content of the third codon position and codon usage biases of human genes. Gene, 261: 53-62. doi:10.1016/S0378-1119(00)00480-7.
33. Tascon, R.E., Colston, M.J., Ragno, S., Stavropoulos, E., Gregory, D., and Lowrie, D.B. 1996. Vaccination against tuberculosis by DNA injection. Nat. Med. 2: 888-892. doi:10.1038/nm0896-888.
34. Vinner, L., Nielsen, H.V., Bryder, K., Corbet, S., Nielsen, C., and Fomsgaard, A. 1999. Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons. Vaccine, 17: 2166-2175. doi:10.1016/S0264-410X(98)00474-5.
35. West, S.K., Rapoza, P., Munoz, B., Katala, S., and Taylor, H.R. 1991. Epidemiology of ocular Chlamydial infection in a trachoma-hyperendemic area. J. Infect. Dis. 163: 752-756.
36. Yang, X. 2003. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr. Pharm. Des. 9: 67-73. doi:10.2174/1381612033392486.
37. Yang, X., Gartner, J., Zhu, L., Wang, S., and Brunham, R.C. 1999. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 162: 1010-1017.
38. Yang, X., Wang, S., Fan, Y., and Han, X. 2000. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur. J. Immunol. 30: 382-391. doi:10.1002/1521- 4141(200002)30:2〈382::AID-IMMU382〉3.0.CO;2-L.
39. Zhang, D., Yang, X., Berry, J., Shen, C., McClarty, G., and Brunham, R.C. 1997. DNA Vaccination with the outer membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumomitis) infection. J. Infect. Dis. 176: 1035-1040.
40. Zhang, D.J., Yang, X., Shen, C., and Brunham, R.C. 1999. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain. Immunology, 96: 314-321. doi:10.1046/j.1365-2567.1999.00682.X.
41. Zhao, W., Yu, X., Zhou, Y., Bian, J., Jia, J., Luan, Y., et al. 2002. Optimized codon usage enhances the expression and immunogenicity of DNA vaccine encoding the HPV 6b E7 gene. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 16: 309-311.
42. Zhou, J., Liu, W.J., Peng, S.W., Sun, X.Y., and Frazer, I. 1999. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J. Virol. 73: 4972-4982.